"Cardiovascular Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Descriptor ID |
D002318
|
| MeSH Number(s) |
C14
|
| Concept/Terms |
Cardiovascular Diseases- Cardiovascular Diseases
- Cardiovascular Disease
- Disease, Cardiovascular
- Diseases, Cardiovascular
|
Below are MeSH descriptors whose meaning is more general than "Cardiovascular Diseases".
Below are MeSH descriptors whose meaning is more specific than "Cardiovascular Diseases".
This graph shows the total number of publications written about "Cardiovascular Diseases" by people in this website by year, and whether "Cardiovascular Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 0 | 1 |
| 2000 | 2 | 2 | 4 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 4 | 2 | 6 |
| 2004 | 7 | 1 | 8 |
| 2005 | 2 | 4 | 6 |
| 2006 | 2 | 4 | 6 |
| 2007 | 6 | 5 | 11 |
| 2008 | 5 | 5 | 10 |
| 2009 | 10 | 5 | 15 |
| 2010 | 12 | 3 | 15 |
| 2011 | 15 | 3 | 18 |
| 2012 | 11 | 7 | 18 |
| 2013 | 19 | 2 | 21 |
| 2014 | 12 | 4 | 16 |
| 2015 | 15 | 4 | 19 |
| 2016 | 60 | 9 | 69 |
| 2017 | 599 | 176 | 775 |
| 2018 | 600 | 148 | 748 |
| 2019 | 260 | 63 | 323 |
| 2020 | 255 | 74 | 329 |
| 2021 | 95 | 37 | 132 |
| 2022 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cardiovascular Diseases" by people in Profiles.
-
Exercise rehabilitation associates with lower mortality and hospitalisation in cardiovascular disease patients with COVID-19. Eur J Prev Cardiol. 2022 02 19; 29(1):e32-e34.
-
Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm? Blood Coagul Fibrinolysis. 2021 Dec 01; 32(8):544-549.
-
The use of statins was associated with reduced COVID-19 mortality: a systematic review and meta-analysis. Ann Med. 2021 12; 53(1):874-884.
-
Ongoing Citations of a Retracted Study Involving Cardiovascular Disease, Drug Therapy, and Mortality in COVID-19. JAMA Intern Med. 2021 11 01; 181(11):1535-1537.
-
Prevalence and Associated Factors of SARS by Covid-19 in Adults and Aged People with Chronic Cardiovascular Disease. Arq Bras Cardiol. 2021 11; 117(5):968-975.
-
Prevalence of abnormal cardiovascular magnetic resonance findings in recovered patients from COVID-19: a systematic review and meta-analysis. J Cardiovasc Magn Reson. 2021 09 03; 23(1):100.
-
Pharmacotherapeutic agents for the management of COVID-19 patients with preexisting cardiovascular disease. Expert Opin Pharmacother. 2021 Dec; 22(18):2455-2474.
-
Post-COVID-19 cardiological alterations. Sao Paulo Med J. 2021 08 30; 139(6):543-544.
-
An organ systems-based review of outcomes associated with sleep apnea in hospitalized patients. Medicine (Baltimore). 2021 Aug 27; 100(34):e26857.
-
Impacts of COVID-19 on essential health services in Tigray, Northern Ethiopia: A pre-post study. PLoS One. 2021; 16(8):e0256330.